[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 83,968,888
  • Shares Outstanding, K 1,486,175
  • Annual Sales, $ 20,074 M
  • Annual Income, $ 2,898 M
  • EBIT $ 4,699 M
  • EBITDA $ 6,113 M
  • 60-Month Beta 0.62
  • Price/Sales 4.27
  • Price/Cash Flow 14.28
  • Price/Book 3.49

Options Overview Details

View History
  • Implied Volatility 35.15% (+0.35%)
  • Historical Volatility 48.30%
  • IV Percentile 82%
  • IV Rank 54.87%
  • IV High 49.76% on 03/27/26
  • IV Low 17.38% on 07/29/25
  • Expected Move (DTE 5) 1.67 (2.96%)
  • Put/Call Vol Ratio 0.87
  • Today's Volume 13,072
  • Volume Avg (30-Day) 21,621
  • Put/Call OI Ratio 0.51
  • Today's Open Interest 305,117
  • Open Int (30-Day) 347,873
  • Expected Range 54.83 to 58.17

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 31 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.84
  • Number of Estimates 8
  • High Estimate $0.84
  • Low Estimate $0.83
  • Prior Year $0.75
  • Growth Rate Est. (year over year) +12.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
56.05 +0.80%
on 04/30/26
66.88 -15.52%
on 04/23/26
-5.50 (-8.87%)
since 04/01/26
3-Month
56.05 +0.80%
on 04/30/26
94.18 -40.01%
on 02/02/26
-37.03 (-39.59%)
since 01/30/26
52-Week
56.05 +0.80%
on 04/30/26
109.50 -48.40%
on 09/09/25
-46.69 (-45.25%)
since 05/01/25

Most Recent Stories

More News
Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , May 1, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action...

BSX : 56.50 (-1.93%)
BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Boston Scientific To Contact Him Directly To Discuss Their Options

BSX : 56.50 (-1.93%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines - BSX

NEW YORK , April 30, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX)....

BSX : 56.50 (-1.93%)
Deadline Soon: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz reminds investors of the upcoming May 4, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on...

BSX : 56.50 (-1.93%)
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented U.S. Electrophysiology Market Growth and Downplayed Competitive Pressures: SueWallSt

The Red Flags: What Insiders Allegedly Knew Before Shareholders Did

BSX : 56.50 (-1.93%)
Boston Scientific Stock: Is Wall Street Bullish or Bearish?

Boston Scientific has lagged behind the broader market over the past year, yet analysts remain highly bullish about the stock’s prospects.

XLV : 145.16 (-0.57%)
BSX : 56.50 (-1.93%)
$SPX : 7,230.12 (+0.29%)
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Hid Weakening U.S. Electrophysiology Sales Trends: Levi & Korsinsky

Deadline Alert: Understanding Lead Plaintiff Selection Under the PSLRA

BSX : 56.50 (-1.93%)
The 5 Most Interesting Analyst Questions From Boston Scientific’s Q1 Earnings Call

The 5 Most Interesting Analyst Questions From Boston Scientific’s Q1 Earnings Call

BSX : 56.50 (-1.93%)
Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , April 28, 2026 /PRNewswire/ --  The Law Offices of Frank R. Cruz announces that investors with losses related to Boston Scientific Corporation ("Boston Scientific" or the "Company")...

BSX : 56.50 (-1.93%)
Massively Disappointing Boston Scientific (BSX) Stock Could Be Due for a Comeback

Although a seemingly inopportune acquisition appears to have cost Boston Scientific dearly, the current valuation of BSX stock may be too enticing to pass up.

BSX : 56.50 (-1.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and...

See More

Key Turning Points

3rd Resistance Point 59.28
2nd Resistance Point 58.73
1st Resistance Point 57.61
Last Price 56.50
1st Support Level 55.94
2nd Support Level 55.39
3rd Support Level 54.27

See More

52-Week High 109.50
Fibonacci 61.8% 89.08
Fibonacci 50% 82.78
Fibonacci 38.2% 76.47
Last Price 56.50
52-Week Low 56.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.